Total Payments
$75,151
2024 Payments
$425.68
Companies
62
Transactions
797
Medicare Patients
1,516
Medicare Billing
$317,365
Payment Breakdown by Category
Other$37,138 (49.4%)
Consulting$19,425 (25.8%)
Food & Beverage$12,493 (16.6%)
Travel$5,407 (7.2%)
Education$687.94 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $37,138 | 34 | 49.4% |
| Consulting Fee | $19,425 | 7 | 25.8% |
| Food and Beverage | $12,493 | 721 | 16.6% |
| Travel and Lodging | $5,407 | 22 | 7.2% |
| Education | $687.94 | 7 | 0.9% |
| Unspecified | $0 | 6 | 0.0% |
Payments by Type
General
$75,151
791 transactions
Ownership
$0
6 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $32,764 | 88 | $0 (2024) |
| Allergan, Inc. | $19,985 | 48 | $0 (2021) |
| Alexion Pharmaceuticals, Inc. | $11,696 | 36 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $2,310 | 144 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,156 | 79 | $0 (2024) |
| Avanir Pharmaceuticals, Inc. | $670.05 | 31 | $0 (2022) |
| ARGENX US, INC. | $521.53 | 2 | $0 (2023) |
| Lundbeck LLC | $373.13 | 26 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $364.89 | 23 | $0 (2022) |
| Biogen, Inc. | $343.85 | 20 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $425.68 | 22 | MITSUBISHI TANABE PHARMA AMERICA, INC. ($53.94) |
| 2023 | $434.86 | 24 | Novartis Pharmaceuticals Corporation ($82.61) |
| 2022 | $1,867 | 79 | ARGENX US, INC. ($500.00) |
| 2021 | $11,688 | 114 | Allergan, Inc. ($6,057) |
| 2020 | $9,794 | 106 | Alexion Pharmaceuticals, Inc. ($5,174) |
| 2019 | $17,594 | 129 | Mitsubishi Tanabe Pharma America, Inc. ($9,645) |
| 2018 | $27,898 | 158 | Mitsubishi Tanabe Pharma America, Inc. ($21,425) |
| 2017 | $5,450 | 165 | Allergan Inc. ($3,209) |
All Payment Transactions
797 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: Neurology | ||||||
| 12/18/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: Neuropsychiatry | ||||||
| 12/11/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: Neurology | ||||||
| 11/22/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Food and Beverage | Cash or cash equivalent | $24.88 | General |
| Category: NEUROLOGY | ||||||
| 10/11/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: Immunology and Neurology | ||||||
| 10/09/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Neuropsychiatry | ||||||
| 10/04/2024 | Biogen, Inc. | SPINRAZA (Biological) | Food and Beverage | In-kind items and services | $28.73 | General |
| Category: Neurology | ||||||
| 09/11/2024 | MITSUBISHI TANABE PHARMA AMERICA, INC. | RADICAVA (Drug), RADICAVA ORS | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: AMYOTROPHIC LATERAL SCLEROSIS | ||||||
| 08/21/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Genetic Disease | ||||||
| 07/26/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: Rare Disease | ||||||
| 06/12/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $14.74 | General |
| Category: NEUROLOGY | ||||||
| 05/31/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Neurology | ||||||
| 05/29/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: Immunology | ||||||
| 05/03/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Genetic Disease | ||||||
| 05/01/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: Central Nervous System | ||||||
| 04/24/2024 | MITSUBISHI TANABE PHARMA AMERICA, INC. | RADICAVA (Drug), RADICAVA ORS | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: AMYOTROPHIC LATERAL SCLEROSIS | ||||||
| 04/21/2024 | Octapharma USA, Inc. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: IMMUNOLOGY | ||||||
| 04/05/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: NEUROLOGY | ||||||
| 04/03/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Neurology | ||||||
| 03/20/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: Rare Disease | ||||||
| 01/10/2024 | MITSUBISHI TANABE PHARMA AMERICA, INC. | RADICAVA (Drug), RADICAVA ORS | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: AMYOTROPHIC LATERAL SCLEROSIS | ||||||
| 01/02/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: Central Nervous System | ||||||
| 12/22/2023 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Genetic Disease | ||||||
| 12/21/2023 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $20.25 | General |
| 12/15/2023 | MITSUBISHI TANABE PHARMA AMERICA, INC. | RADICAVA (Drug), RADICAVA ORS | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: AMYOTROPHIC LATERAL SCLEROSIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 257 | 286 | $57,445 | $27,740 |
| 2022 | 7 | 365 | 435 | $89,925 | $45,276 |
| 2021 | 11 | 405 | 9,864 | $192,456 | $96,200 |
| 2020 | 15 | 489 | 18,900 | $312,590 | $148,149 |
Total Patients
1,516
Total Services
29,485
Medicare Billing
$317,365
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 124 | 151 | $18,120 | $10,981 | 60.6% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 50 | 51 | $15,300 | $6,629 | 43.3% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 32 | 32 | $11,200 | $5,126 | 45.8% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 24 | 25 | $7,500 | $2,309 | 30.8% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 11 | 11 | $4,125 | $1,933 | 46.9% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2023 | 16 | 16 | $1,200 | $762.40 | 63.5% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 176 | 245 | $29,400 | $18,636 | 63.4% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 45 | 45 | $15,750 | $6,957 | 44.2% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 44 | 44 | $13,200 | $5,719 | 43.3% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2022 | 24 | 24 | $10,200 | $5,444 | 53.4% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 44 | 44 | $13,200 | $4,432 | 33.6% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2022 | 19 | 19 | $7,125 | $3,377 | 47.4% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2022 | 13 | 14 | $1,050 | $710.64 | 67.7% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 26 | 9,420 | $90,401 | $44,267 | 49.0% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 155 | 199 | $23,880 | $15,959 | 66.8% |
| 95910 | Nerve transmission studies, 7-8 studies | Office | 2021 | 60 | 60 | $18,000 | $7,938 | 44.1% |
| 95911 | Nerve transmission studies, 9-10 studies | Office | 2021 | 37 | 37 | $12,950 | $6,475 | 50.0% |
| 64616 | Injection of chemical for destruction of nerve muscles on one side of neck excluding voice box accessed through the skin | Office | 2021 | 19 | 31 | $14,750 | $4,649 | 31.5% |
| 95913 | Nerve transmission studies, 13 or more studies | Office | 2021 | 15 | 15 | $6,375 | $3,574 | 56.1% |
| 95909 | Nerve transmission studies, 5-6 studies | Office | 2021 | 31 | 31 | $9,300 | $3,513 | 37.8% |
| 95912 | Nerve transmission studies, 11-12 studies | Office | 2021 | 14 | 15 | $5,625 | $3,132 | 55.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 19 | 23 | $4,600 | $2,991 | 65.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 13 | 13 | $3,575 | $1,967 | 55.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 16 | 20 | $3,000 | $1,735 | 57.8% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2020 | 29 | 18,300 | $175,680 | $87,174 | 49.6% |
About Dr. Tomas Holmlund, M.D
Dr. Tomas Holmlund, M.D is a Neurology healthcare provider based in Amherst, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1770644528.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tomas Holmlund, M.D has received a total of $75,151 in payments from pharmaceutical and medical device companies, with $425.68 received in 2024. These payments were reported across 797 transactions from 62 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($37,138).
As a Medicare-enrolled provider, Holmlund has provided services to 1,516 Medicare beneficiaries, totaling 29,485 services with total Medicare billing of $317,365. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Amherst, NY
- Active Since 12/13/2006
- Last Updated 05/29/2018
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1770644528
Products in Payments
- Radicava (Drug) $26,500
- BOTOX (Biological) $13,243
- BOTOX (Drug) $6,440
- RADICAVA (Drug) $6,263
- Soliris (Drug) $5,346
- AUSTEDO (Drug) $723.95
- VYVGART (Drug) $521.53
- COPAXONE (Drug) $507.64
- KESIMPTA (Drug) $463.10
- NUPLAZID (Drug) $364.89
- Nuedexta (Drug) $342.73
- NUEDEXTA (Drug) $327.32
- ONPATTRO (Drug) $309.79
- Rebif (Biological) $301.68
- NORTHERA (Drug) $292.26
- AUBAGIO (Drug) $264.61
- GOCOVRI (Drug) $262.27
- AIMOVIG (Biological) $251.78
- AJOVY (Biological) $249.84
- XEOMIN (Biological) $221.40
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Amherst
Nicolas Saikali, Md, MD
Neurology — Payments: $1.7M
Neurology $1.7M
Dr. Jennifer Mcvige, M.d, M.D
Neurology — Payments: $1.0M
Neurology $1.0M
Bennett Myers, M.d, M.D
Neurology — Payments: $538,477
Neurology $538,477
Laszlo Mechtler, Md, MD
Neurology — Payments: $430,778
Neurology $430,778
Dr. Wisam Elmalik, M.d, M.D
Neurology — Payments: $321,171
Neurology $321,171
Dr. Bela Ajtai, Md, Phd, MD, PHD
Neurology — Payments: $135,293
Neurology $135,293